Physiologically based approaches towards the prediction of pharmacokinetics:in vitro–in vivo extrapolation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
In adapting to the challenge to make more informed selection of compounds for development, the pharmaceutical industry is increasingly embracing the application of mechanism-based models and prediction tools for prediction of pharmacokinetic parameters. This review first outlines the concepts and application of the major physiologically based prediction tools to extrapolate clearance, tissue distribution, and rate and extent of absorption from minimal in vitro or animal in vivo input data. Finally, the ability of these prediction tools, when placed within a generic whole body physiologically based model of pharmacokinetics, to predict plasma concentration-time profiles is briefly discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obach, R. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14938-0 · Cited by 1,232
The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
Brian Houston, J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90520-7 · Cited by 925 · cited 2×
“Excellent in-depth reviews dealing with this methodology can be found in the literature [8,16,17] .”
BackgroundPang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059688 · Cited by 797 · cited 1×
“1 General concepts As the liver is the most important organ for drug metabolism, physiologically based prediction of hepatic drug clearance (CL H ) from in vitro data has been the focus of much of this modeling [5-7] .”
BackgroundRodgers, T., Leahy, D., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20322 · Cited by 776 · cited 5×
“have developed a new tissue composition-based approach and showed it to improve the predictability of P tp over the equations developed by Poulin and Theil [77,79] .”
BackgroundMethodInfluentialPredicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability
Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00179-x · Cited by 651
Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics
Boxenbaum, H. (1982) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062336 · Cited by 648 · cited 1×
“For example, allometric scaling, which considers that a number of anatomical, physiological and biochemical variables and can be scaled across species as a power function of the bodyweight, has been the dominant method for interspecies scaling of human PK parameters [105-107] .”
MethodPoulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568 · cited 6×
“This may be explained by different physicochemical properties [76] as well as by distribution processes that are not covered in these equations, such as active transport, specific macromolecular binding, limitation for membrane permeation and ionic interactions [60] .”
BackgroundInfluentialJohnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00005 · Cited by 530 · cited 1×
“Physiologically based predictions can also be used to rationalise the ‘first in human’ decision making process as well as to improve the design of the study by enabling the prediction of food effects [94] , intersubject PK variability [34] and prediction of PK in children and neonates based on information dealing with…”
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data
Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., & Sugiyama, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00184-2 · Cited by 479 · cited 3×
“Excellent in-depth reviews dealing with this methodology can be found in the literature [8,16,17] .”
BackgroundLeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Barter, Z., Bayliss, M., Beaune, P., Boobis, A., Carlile, D., Edwards, R., Brian Houston, J., Lake, B., Lipscomb, J., Pelkonen, O., et al. (2007) · Current Drug Metabolism · doi:10.2174/138920007779315053 · Cited by 459 · cited 1×
“A variety of different values have been invoked for the scaling factors of rat and human microsomal protein and hepatocellularity per gram of liver [22] .”
BackgroundDevelopment and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children
Edginton, A. N., Schmitt, W., & Willmann, S. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00005 · Cited by 357 · cited 1×
“Physiologically based predictions can also be used to rationalise the ‘first in human’ decision making process as well as to improve the design of the study by enabling the prediction of food effects [94] , intersubject PK variability [34] and prediction of PK in children and neonates based on information dealing with…”
MethodA Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics
Jones, H. M., Parrott, N., Jorga, K., & Lav??, T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645050-00006 · Cited by 352 · cited 6×
“Prediction of absorption of such compounds was found to be prone to underprediction in both rats [44,76] and humans [45,74] , and bias towards underprediction correlated to very low aqueous solubility.”
BackgroundResultInfluentialDe Buck, S. S., Sinha, V. K., Fenu, L. A., Nijsen, M. J., Mackie, C. E., & Gilissen, R. A. H. J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015644 · Cited by 256 · cited 5×
“Prediction of absorption of such compounds was found to be prone to underprediction in both rats [44,76] and humans [45,74] , and bias towards underprediction correlated to very low aqueous solubility.”
BackgroundResultSelf-citationCorrelation of Biliary Excretion in Sandwich-Cultured Rat Hepatocytes and In Vivo in Rats
Liu, X., Chism, J. P., LeCluyse, E. L., Brouwer, K. R., & Brouwer, K. L. R. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15299-3 · Cited by 228
Lave, T. H., Dupin, S., Schmitt, C., Chou, R. C., Jaeck, D., & Coassolo, P. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960440h · Cited by 184 · cited 1×
“Attempts have been made to improve predictions in these cases by applying correction factors for protein binding, brain weight, maximum lifespan potential and in vitro hepatic CL int data, with varying degree of uccess [105,110,111] .”
Prediction of intestinal absorption: comparative assessment of gastroplus™ and idea™
Parrott, N., & Lavé, T. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00132-x · Cited by 170
Lav??, T., Coassolo, P., & Reigner, B. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936030-00003 · Cited by 162 · cited 1×
“Other approaches include the incorporation of both physiologically based scaling and the use of a drug-specific correction factor, which can be derived from the in vitro – in vivo CL int ratio in rats or dog [47] , or a more complex cross-species regression analysis between the in vitro CL int and in vivo CL H in vari…”
MethodPhysiologically-based pharmacokinetic simulation modelling
Grass, G. M., & Sinko, P. J. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00013-3 · Cited by 160
Willmann, S., Lippert, J., & Schmitt, W. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.1.159 · Cited by 140
Parrott, N., Paquereau, N., Coassolo, P., & Lavé, T. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20419 · Cited by 107 · cited 4×
“This may be explained by different physicochemical properties [76] as well as by distribution processes that are not covered in these equations, such as active transport, specific macromolecular binding, limitation for membrane permeation and ionic interactions [60] .”
BackgroundInfluentialLavé, T., Dupin, S., Schmitt, C., Valles, B., Ubeaud, G., Chou, R. C., Jaeck, D., & Coassolo, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012036324237 · Cited by 106 · cited 3×
“The latter is in line with reports illustrating that underprediction is much less pronounced when using freshly isolated as compared with cryopreserved human hepatocytes [24-26] .”
BackgroundResultMahmood, I., & Balian, J. D. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950400y · Cited by 105 · cited 1×
“Attempts have been made to improve predictions in these cases by applying correction factors for protein binding, brain weight, maximum lifespan potential and in vitro hepatic CL int data, with varying degree of uccess [105,110,111] .”
Prediction of Hepatic Metabolic Clearance: Comparison and Assessment of Prediction Models
Zuegge, J., Schneider, G., Coassolo, P., & Lav??, T. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00006 · Cited by 92
Prediction of metabolic drug clearance in humans:In vitro–in vivoextrapolationvsallometric scaling
Shiran, M. R., Proctor, N. J., Howgate, E. M., Rowland-Yeo, K., Tucker, G. T., & Rostami-Hodjegan, A. (2006) · Xenobiotica · doi:10.1080/00498250600761662 · Cited by 89 · cited 2×
“Despite these uncertainties, physiologically based scaling has often been found to provide more accurate results compared to allometric scaling of preclinical data [19,49,50] .”
BackgroundResultInterspecies scaling of biliary excreted drugs
Mahmood, I., & Sahajwalla, C. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10174 · Cited by 62
Cited by
Computational Approaches in Preclinical Studies on Drug Discovery and Development
Wu, F., Zhou, Y., Li, L., Shen, X., Chen, G., Wang, X., Liang, X., Tan, M., & Huang, Z. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00726 · Cited by 446
Wetmore, B. A., Wambaugh, J. F., Ferguson, S. S., Sochaski, M. A., Rotroff, D. M., Freeman, K., Clewell, H. J., Dix, D. J., Andersen, M. E., Houck, K. A., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfr254 · Cited by 415
Heikkinen, A. T., Baneyx, G., Caruso, A., & Parrott, N. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.06.013 · Cited by 76
Metadata
- Authors
- De Buck, S. S., & Mackie, C. E.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2007-11-21
- Volume
- 3
- Issue
- 6
- Pages
- 865-878
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2014332478
- Cited by
- 58
- References
- 27
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.